PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

American Society of Anesthesiologists names Donald E. Arnold, M.D., FACHE, FASA, new president

2024-10-23
(Press-News.org) PHILADELPHIA — Donald E. Arnold, M.D., FACHE, FASA, chair of the Department of Anesthesiology, Mercy Hospital in St. Louis and member of the board of directors of Western Anesthesiology Associates, Inc., in Ballwin, Missouri, was today named president of the American Society of Anesthesiologists (ASA), the nation’s largest organization of anesthesiologists. Dr. Arnold assumed office at the ANESTHESIOLOGY® 2024 annual meeting and will serve for one year.

“I’m honored to be named president of ASA and committed to serving our members, supporting the Society’s mission to advance the specialty, preserving physician-led anesthesia care, and above all, providing safe, high-quality patient care,” said Dr. Arnold. “I look forward to addressing the challenges facing our specialty and working alongside our members with proactive advocacy that tackles the issues affecting our practices, such as the broken Medicare physician payment system, holding insurers accountable in payment disputes and workforce imbalances. I am also dedicated to continuing ASA’s long tradition of providing quality education, supporting scientific research and offering valuable programs that help our diverse membership thrive at every stage of their careers.”

Dr. Arnold is a member of ASA’s Executive Committee and Administrative Council. He has served ASA in numerous roles, including treasurer and assistant treasurer. He is chair of the Budget Committee and vice chair of the Committee on Representation to the World Federation of Societies of Anaesthesiologists. He has also chaired ASA’s Section on Fiscal Affairs, Committee on Quality Management and Departmental Administration, Ad Hoc Committee on Deep Sedation and Education, and Ad Hoc Committee on Payment and Care Delivery Models. Dr. Arnold was also a director and officer of the Anesthesia Quality Institute and a director and officer of the Foundation for Anesthesia Education and Research.

In addition to his commitments to ASA, Dr. Arnold has served as a full examiner and senior editor for the Standardized Oral Exam for the American Board of Anesthesiology, guest reviewer for Anesthesia & Analgesia and ASA liaison to The Joint Commission. He served as president of the Missouri Society of Anesthesiologists (MSA) and St. Louis Society of Anesthesiologists. Dr. Arnold serves on the board of directors for the Mercy East Communities. He has been recognized by the MSA with its Distinguished Service Award and by Mercy with the Charles E. Thoele Physician Leadership Award.

“Dr. Arnold’s wisdom, expertise and vision will ensure the Society’s success in the coming year, and for years to come,” said ASA Immediate Past President Ronald L. Harter, M.D., FASA. “His knowledge of the many important issues facing our specialty is unparalleled. His perspective and thoughtful analysis of our members’ needs amid the rapidly changing health care environment are positioning ASA and our members to flourish, while keeping patient safety at the center of all that we do.” 

Dr. Arnold received his medical degree from the University of Wisconsin School of Medicine and Public Health, Madison. He completed his transitional internship at Hartford Hospital, Connecticut, and his residency in anesthesiology at Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire. He is board-certified in anesthesiology. Dr. Arnold resides in St. Louis with his wife, Tamara K. Ehlert, M.D.; they have three adult children.

THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS
Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 58,000 members organized to advance the medical practice of anesthesiology and secure its future. ASA is committed to ensuring anesthesiologists evaluate and supervise the medical care of all patients before, during and after surgery. ASA members also lead the care of critically ill patients in intensive care units, as well as treat pain in both acute and chronic settings.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about how anesthesiologists help ensure patient safety, visit asahq.org/madeforthismoment. Join the ANESTHESIOLOGY® 2024 social conversation today. Like ASA on Facebook, follow ASALifeline on X and use the hashtag #ANES24.

# # #

END



ELSE PRESS RELEASES FROM THIS DATE:

Family as a wealth factor

2024-10-23
Wealth is one of the strongest indicators of social status, acting as a key indicator of social inequality and influencing access to education, health care and professional success. In a study, researchers from the Max Planck Institute for Demographic Research, the University of Cologne, GESIS and the Norwegian Institute of Public Health examined how financial wealth changes related to various generational transitions within families. The study used data from Norwegian registries and focused on people born in 1953. Investigating changes in wealth within the ...

Breathing deep: A metabolic secret of ethane-consuming archaea unraveled

Breathing deep: A metabolic secret of ethane-consuming archaea unraveled
2024-10-23
Seeps on the deep seafloor naturally emit alkanes, which are pollutants that are potentially dangerous to life and act on global warming. Fortunately, the sediments around the seeps host microbes that act as a biological filter: They consume most of the alkanes before their release into the oceans and our atmosphere. This so-called anaerobic oxidation of alkanes is an important yet poorly understood microbial process. Scientists from the Max Planck Institute for Marine Microbiology in Bremen, Germany, now ...

NIH clinical trial will test precision medicine treatments for myeloid cancers

2024-10-23
The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The trial, funded by NIH’s National Cancer Institute (NCI), aims to accelerate the discovery of more tailored treatments for these aggressive cancers of the blood and bone marrow. “AML and MDS are a heterogeneous group of cancers that can progress very quickly. Treatment advances depend in part on the ability to rapidly identify which subtype of cancer each patient has so that treatments can be tested for ...

Novel antibody platform tackles viral mutations

Novel antibody platform tackles viral mutations
2024-10-23
New York, NY, October 23, 2024 — Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies. Their findings, including preclinical studies in mice, introduce the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, a new antibody approach for addressing how viruses like SARS-CoV-2, which causes COVID-19, evolve to evade vaccines and treatments. Details on the results were published October 23 ...

myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across US and Canada

2024-10-23
Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine treatments for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The Alliance for Clinical Trials in Oncology, Canadian Cancer Trials Group, ECOG-ACRIN Cancer Research Group, and SWOG Cancer Research Network are collaborating within the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) to design and lead the trials. They expect to open ...

Social determinants of health and US health care expenditures by insurer

2024-10-23
About The Study: In this cross-sectional study of 14,000 insured adults, individual-level social determinants of health were significantly associated with U.S. health care expenditures by Medicare, Medicaid, and private insurers. These findings may inform health insurers and policymakers to incorporate social determinants of health in their decision-making practices to identify and control health care expenditures, advancing health equity.  Corresponding Author: To contact the corresponding author, Giridhar Mohan, MPH, email gmohan1@jhu.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.40467) Editor’s ...

Traumatic and adverse childhood experiences and developmental differences in psychiatric risk

2024-10-23
About The Study: In this cohort study, distinct forms of traumatic and adverse childhood experiences differentially moderated developmental changes in psychiatric risk and cognitive ability in different ways, offering the possibility for precision-based prediction of risk for youth. Such findings could be used in targeted early prevention and intervention strategies for at-risk youth.  Corresponding Author: To contact the corresponding author, Justin D. Russell, PhD, email jdrussell3@wisc.edu To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (10.1001/jamapsychiatry.2024.3231) Editor’s ...

Immunotherapy blocks scarring, improves heart function in mice with heart failure

Immunotherapy blocks scarring, improves heart function in mice with heart failure
2024-10-23
A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy — similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory conditions such as arthritis — also may be an effective treatment strategy for heart failure. The study is published Oct. 23 in the journal Nature. After a heart attack, viral infection or other injury to the heart, scar tissue often forms in the heart muscle, where it interferes with the heart’s normal contractions and plays a leading role in heart failure, the progressive loss of the heart’s ...

Discovery finds how ovarian cancer disables immune cells

Discovery finds how ovarian cancer disables immune cells
2024-10-23
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The work, published Oct. 23 in Nature, points toward a promising new immunotherapy approach for ovarian cancer, which is notoriously aggressive and hard to treat. A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and blood vessels that shields cancer cells from the immune system. Within this hostile environment, T cells lose their ability to take up the lipid (fat) molecules, which are necessary for energy to mount ...

Physicists discover first “black hole triple”

Physicists discover first “black hole triple”
2024-10-23
Many black holes detected to date appear to be part of a pair. These binary systems comprise a black hole and a secondary object — such as a star, a much denser neutron star, or another black hole — that spiral around each other, drawn together by the black hole’s gravity to form a tight orbital pair.  Now a surprising discovery is expanding the picture of black holes, the objects they can host, and the way they form.  In a study appearing in Nature, physicists at MIT and Caltech report that they have observed a “black hole triple” for the first time. The new system holds a central black hole in the act of consuming a small star ...

LAST 30 PRESS RELEASES:

Fossils unveil how southern Europe’s ecosystem changed through Glacial-Interglacial Stages

Your ability to balance on one leg may be a reliable indicator of neuromuscular aging, with men and women showing significant declines over the decades

Most young adults in the UK consider non-consensual condom removal during sex to be wrong and a violation of consent, with almost 9 in 10 seeing it as a form of sexual assault, per survey of 18-25-yea

Under climate change scenarios, 30-44% more land in Ethiopia might become suitable for growing arabica coffee by 2080, although some cultivated areas might also become unsuitable, per modelling study

Cockroaches and maggots might be able to turn an invasive seaweed into a high quality compost, finds a new experimental study which provides hope for the environment and the circular economy

Implantable device may prevent death from opioid overdose

Half of young adults support prison time for non-consensual condom removal

‘Paleo-robots’ to help scientists understand how fish started to walk on land

Study: Robotic automation, AI will speed up scientific progress in science laboratories

Paleontologists discover Colorado ‘swamp dweller’ that lived alongside dinosaurs

Repeated COVID vaccines enhance mucosal immunity against the virus

MD Anderson expands arts experience program to enhance healing and well-being for patients

Students at Historically Black Colleges and Universities (HBCUs) face barriers to medical school admission, study finds

Symbiosis in ancient Corals

Researchers receive grant to study invasive autumn olive

New research shows urine tests may detect early diseases

Antibiotics and antifungals may slightly affect Parkinson's risk, study finds

Nixing narcolepsy nightmares

Mass General Brigham selected to receive $3.29 million award from ARPA-H’s Sprint for Women’s Health

The decision to eat may come down to these three neurons

Woods Hole Oceanographic Institution researchers use the sounds of healthy coral reefs to encourage growth of a new species of coral larvae

Researchers at NYU Tandon School of Engineering and KAIST develop method to 'hear' defects in promising nanomaterial

Biodiversity increases nutrient availability

American Society of Anesthesiologists names Donald E. Arnold, M.D., FACHE, FASA, new president

Family as a wealth factor

Breathing deep: A metabolic secret of ethane-consuming archaea unraveled

NIH clinical trial will test precision medicine treatments for myeloid cancers

Novel antibody platform tackles viral mutations

myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across US and Canada

Social determinants of health and US health care expenditures by insurer

[Press-News.org] American Society of Anesthesiologists names Donald E. Arnold, M.D., FACHE, FASA, new president